Why is the stock of Ziopharm Oncology IN (ZIOP) soaring in aftermarket?
ZIOP is experiencing an increase of 19.39% in the aftermarket on Friday. However, the normal trading session closed at $0.12 with a decrease of 6.78%. Participation in September Investor Conferences by ZIOP On 1st September 2021, Kevin S. Boyle, Sr., Ziopharm’s Chief Executive Officer, has announced to participate at 5 forthcoming virtual investor conferences: ZIOP […]
Why is the stock of Ziopharm Oncology IN (ZIOP) soaring in aftermarket? Read More »